Search

everythinglearnresearchcommunity

for

Search:↓

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

More research is needed to understand hair and scalp disorders in people with skin of color.

Trichoscopy is a useful tool for diagnosing and managing hair and scalp conditions, often better than traditional methods.

Hair transplant surgery may cause alopecia areata, a new possible complication.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

People with alopecia areata often have lower vitamin D levels than healthy people.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

A thorough skin history and full examination are important for diagnosing and understanding the impact of skin diseases.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

Hair follicle stem cells have significant potential for treating various disorders.

Treat hair loss with medicine, continue indefinitely.

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Careful planning and accurate diagnosis are crucial for successful hair restoration surgery.

Latanoprost is more effective than minoxidil for treating alopecia areata.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Both treatments for alopecia areata showed similar modest effectiveness.